NO20005145L - FremgangsmÕte for behandling av fertilitetsproblemer - Google Patents

FremgangsmÕte for behandling av fertilitetsproblemer

Info

Publication number
NO20005145L
NO20005145L NO20005145A NO20005145A NO20005145L NO 20005145 L NO20005145 L NO 20005145L NO 20005145 A NO20005145 A NO 20005145A NO 20005145 A NO20005145 A NO 20005145A NO 20005145 L NO20005145 L NO 20005145L
Authority
NO
Norway
Prior art keywords
procedure
fertility problems
treating fertility
treating
antagonists
Prior art date
Application number
NO20005145A
Other languages
English (en)
Other versions
NO20005145D0 (no
NO326406B1 (no
Inventor
Juergen Engel
Hilde Riethmueller-Winzen
Thomas Reissmann
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO20005145L publication Critical patent/NO20005145L/no
Publication of NO20005145D0 publication Critical patent/NO20005145D0/no
Publication of NO326406B1 publication Critical patent/NO326406B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/52—Sperm; Prostate; Seminal fluid; Leydig cells of testes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Liquid Crystal Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005145A 1998-04-23 2000-10-13 Anvendelse av en LHRH-antagonist for fremstilling av medikament for behandling av infertilitet. NO326406B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8274398P 1998-04-23 1998-04-23
PCT/EP1999/002133 WO1999055357A1 (en) 1998-04-23 1999-03-29 Method for the treatment of fertility disorders

Publications (3)

Publication Number Publication Date
NO20005145L true NO20005145L (no) 2000-10-13
NO20005145D0 NO20005145D0 (no) 2000-10-13
NO326406B1 NO326406B1 (no) 2008-11-24

Family

ID=22173160

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005145A NO326406B1 (no) 1998-04-23 2000-10-13 Anvendelse av en LHRH-antagonist for fremstilling av medikament for behandling av infertilitet.

Country Status (24)

Country Link
US (1) US6319192B1 (no)
EP (1) EP1082129B1 (no)
JP (1) JP2002512975A (no)
KR (1) KR100632722B1 (no)
AT (1) ATE252910T1 (no)
AU (1) AU752415B2 (no)
BR (1) BR9909802A (no)
CA (1) CA2330131C (no)
CZ (1) CZ301912B6 (no)
DE (1) DE69912422T2 (no)
DK (1) DK1082129T3 (no)
ES (1) ES2207941T3 (no)
HU (1) HU228736B1 (no)
IL (1) IL139027A0 (no)
NO (1) NO326406B1 (no)
NZ (1) NZ507405A (no)
PL (1) PL195989B1 (no)
PT (1) PT1082129E (no)
RU (1) RU2221588C2 (no)
SI (1) SI1082129T1 (no)
SK (1) SK285192B6 (no)
TR (1) TR200003063T2 (no)
UA (1) UA66850C2 (no)
WO (1) WO1999055357A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
EP0788799A3 (en) 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
US6623422B2 (en) * 2001-01-12 2003-09-23 Napoli, Llc Method and apparatus for assisted embryo implantation
WO2002067772A2 (en) * 2001-01-12 2002-09-06 Napoli, Llc. Intra-uterine devices and method of use
US8465412B2 (en) * 2001-01-12 2013-06-18 Michael Levy Uterine devices and method of use
US6758806B2 (en) 2001-01-12 2004-07-06 Napoli, Llc Endoscopic devices and method of use
US20060183973A1 (en) * 2001-01-12 2006-08-17 Kamrava Michael M Endoscopic devices and method of use
RU2193888C1 (ru) * 2001-06-08 2002-12-10 Научно-исследовательский институт урологии Способ нормализации репродуктивной функции у мужчин
UA80418C2 (en) * 2001-12-14 2007-09-25 Applied Research Systems Methods of inducing ovulation using phosphodiesterase inhibitor as non-polypeptide camp level modulator.and method of collecting oocytes for in vitro fertilization
US7033314B2 (en) * 2002-01-11 2006-04-25 Fidelitycorp Limited Endoscopic devices and method of use
US20030186892A1 (en) * 2002-03-28 2003-10-02 Rajneesh Taneja Enhancement of endogenous gonadotropin production
US6695766B2 (en) 2002-04-26 2004-02-24 Olympia Womens Health Magnetic embryo transfer
EP1364658A1 (en) * 2002-05-24 2003-11-26 Applied Research Systems ARS Holding N.V. Use of varying ratios of gonadotrophins in controlled ovarian hyperstimulation
US7815912B2 (en) * 2002-06-07 2010-10-19 Ares Trading, S.A. Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
RU2275205C2 (ru) * 2003-08-18 2006-04-27 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "МИКРОГЕН" МЗ РФ Биологически активный комплекс, содержащий фосфолипиды, для лечения псориаза и хронического простатита

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130137A (en) * 1989-08-09 1992-07-14 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders
RU2013989C1 (ru) * 1991-08-13 1994-06-15 Борис Васильевич Леонов Способ определения овуляции
DE4305225A1 (de) 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
DE19604231A1 (de) * 1996-01-29 1997-07-31 Schering Ag Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
EP0788799A3 (en) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US5824548A (en) * 1996-05-29 1998-10-20 Wisconsin Alumni Research Foundation Method of increasing survival of cultured primate embryos in medium containing exogenous gonadotrophin releasor hormone
DE19712718C2 (de) * 1997-03-26 1999-09-23 Asta Medica Ag Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung
US5961444A (en) * 1997-10-17 1999-10-05 Medworks Corporation In vitro fertilization procedure using direct vision

Also Published As

Publication number Publication date
SK15302000A3 (sk) 2001-10-08
EP1082129A1 (en) 2001-03-14
CA2330131A1 (en) 1999-11-04
IL139027A0 (en) 2001-11-25
WO1999055357A1 (en) 1999-11-04
HUP0101528A3 (en) 2001-12-28
NZ507405A (en) 2002-10-25
TR200003063T2 (tr) 2001-02-21
ES2207941T3 (es) 2004-06-01
SK285192B6 (sk) 2006-08-03
BR9909802A (pt) 2000-12-26
HU228736B1 (en) 2013-05-28
NO20005145D0 (no) 2000-10-13
CZ301912B6 (cs) 2010-07-28
KR100632722B1 (ko) 2006-10-16
DE69912422D1 (de) 2003-12-04
SI1082129T1 (en) 2004-02-29
KR20010042873A (ko) 2001-05-25
EP1082129B1 (en) 2003-10-29
PL343609A1 (en) 2001-08-27
RU2221588C2 (ru) 2004-01-20
NO326406B1 (no) 2008-11-24
PT1082129E (pt) 2004-03-31
JP2002512975A (ja) 2002-05-08
AU752415B2 (en) 2002-09-19
PL195989B1 (pl) 2007-11-30
US6319192B1 (en) 2001-11-20
HUP0101528A2 (hu) 2001-11-28
DK1082129T3 (da) 2004-01-26
CZ20003766A3 (cs) 2001-08-15
DE69912422T2 (de) 2004-08-19
ATE252910T1 (de) 2003-11-15
AU3702899A (en) 1999-11-16
CA2330131C (en) 2011-10-25
UA66850C2 (uk) 2004-06-15

Similar Documents

Publication Publication Date Title
NO20005145D0 (no) FremgangsmÕte for behandling av fertilitetsproblemer
ATE215081T1 (de) Gonadotropin releasing hormon- antagonisten
LV11782A (lv) Lidzeklis no oinicu estrogena atkariga stavokla arstesanai
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
ATE183198T1 (de) Immunogens gegen gonadotropin releasing hormone
MXPA04004364A (es) Composiciones para el tratamiento de disfuncion sexual femenina postmenopausica.
CY1105931T1 (el) Χρηση ενος αγωνιστη/ανταγωνιστη οιστρογονου για την αντιμετωπιση γυναικειας σεξουαλικης δυσλειτουργιας
ES2196063T3 (es) Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales.
CY1105370T1 (el) Μεθοδος θepαπειας των κλιμακτηριακων διαταραχων στις εμμηνοπαυσιακες και μετεμμηνοπαυσιακες γυναικες
PT1066304E (pt) Antagonistas macrolidos de lhrh
WO2002056903A3 (en) Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
ES8207511A1 (es) Un procedimiento para la preparacion de nuevos peptidos.
WO2001021194A3 (en) Method for the therapeutic management of endometriosis and fallopian tube obstruction
GR900100489A (el) Συνθέσεις χρήσιμοι ως αντισυλληπτικά για άνδρες.
Schally Hypothalamic regulation of FSH and LH secretion
FI840116A7 (fi) LHRH-antagonisteina hyödylliset LHRH-hormoonin nonapeptidi- ja dekapeptidianalogit.
MX9707008A (es) Uso de antiestrogenos para control natal en hombres.

Legal Events

Date Code Title Description
MK1K Patent expired